| 0 |
ENCEPHALITIS CYTOMEGALOVIRUS |
171 |
0.3904 |
| 1 |
LUNG DISEASE INFECTIVE EXACERBATION |
10 |
0.3704 |
| 2 |
IMMUNE RECOVERY UVEITIS |
21 |
0.3621 |
| 3 |
CYTOMEGALOVIRUS MYOCARDITIS |
11 |
0.3333 |
| 4 |
OESOPHAGOPLEURAL FISTULA |
10 |
0.3125 |
| 5 |
CYTOMEGALOVIRUS SYNDROME |
45 |
0.2727 |
| 6 |
SMOOTH MUSCLE CELL NEOPLASM |
108 |
0.2584 |
| 7 |
RETINITIS VIRAL |
28 |
0.2314 |
| 8 |
FLAVOBACTERIUM INFECTION |
9 |
0.2045 |
| 9 |
CYTOMEGALOVIRUS GASTRITIS |
38 |
0.1502 |
| 10 |
CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION |
44 |
0.1477 |
| 11 |
DISSEMINATED CYTOMEGALOVIRAL INFECTION |
27 |
0.1250 |
| 12 |
CYTOMEGALOVIRUS GASTROENTERITIS |
27 |
0.1250 |
| 13 |
NECROTISING HERPETIC RETINOPATHY |
9 |
0.1216 |
| 14 |
KAPOSI SARCOMA INFLAMMATORY CYTOKINE SYNDROME |
7 |
0.1186 |
| 15 |
CYTOMEGALOVIRUS DUODENITIS |
8 |
0.1143 |
| 16 |
AUTOIMMUNE PANCYTOPENIA |
10 |
0.1099 |
| 17 |
CYTOMEGALOVIRUS OESOPHAGITIS |
39 |
0.1060 |
| 18 |
CYTOMEGALOVIRUS CHORIORETINITIS |
203 |
0.1040 |
| 19 |
CYTOMEGALOVIRUS VIRAEMIA |
434 |
0.0975 |
| 20 |
PNEUMONIA CYTOMEGALOVIRAL |
188 |
0.0967 |
| 21 |
EPSTEIN-BARR VIRAEMIA |
105 |
0.0947 |
| 22 |
BK POLYOMAVIRUS TEST POSITIVE |
9 |
0.0938 |
| 23 |
CYTOMEGALOVIRUS ANTIGEN POSITIVE |
17 |
0.0929 |
| 24 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
397 |
0.0898 |
| 25 |
CYTOMEGALOVIRUS COLITIS |
197 |
0.0856 |
| 26 |
ACANTHAMOEBA INFECTION |
16 |
0.0851 |
| 27 |
VIRAL UVEITIS |
8 |
0.0825 |
| 28 |
ADENOVIRUS REACTIVATION |
11 |
0.0764 |
| 29 |
NEUTROPHIL PELGER-HUET ANOMALY PRESENT |
14 |
0.0749 |
| 30 |
DRUG RESISTANCE MUTATION |
13 |
0.0730 |
| 31 |
CYTOMEGALOVIRUS ENTERITIS |
26 |
0.0730 |
| 32 |
CYTOMEGALOVIRUS INFECTION |
1208 |
0.0726 |
| 33 |
TRACTIONAL RETINAL DETACHMENT |
8 |
0.0721 |
| 34 |
MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS |
11 |
0.0719 |
| 35 |
CYTOMEGALOVIRUS HEPATITIS |
25 |
0.0706 |
| 36 |
VIRAL HAEMORRHAGIC CYSTITIS |
50 |
0.0702 |
| 37 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
51 |
0.0662 |
| 38 |
NECROTISING RETINITIS |
41 |
0.0641 |
| 39 |
INTRACRANIAL INFECTION |
8 |
0.0640 |
| 40 |
GRAFT VERSUS HOST DISEASE IN INTESTINE |
8 |
0.0615 |
| 41 |
SELECTIVE IGA IMMUNODEFICIENCY |
9 |
0.0612 |
| 42 |
HUMAN HERPESVIRUS 8 INFECTION |
37 |
0.0608 |
| 43 |
GASTROINTESTINAL MUCORMYCOSIS |
10 |
0.0599 |
| 44 |
PARVOVIRUS INFECTION |
24 |
0.0594 |
| 45 |
RHEGMATOGENOUS RETINAL DETACHMENT |
12 |
0.0574 |
| 46 |
INFECTED NEOPLASM |
14 |
0.0562 |
| 47 |
CYTOMEGALOVIRUS TEST POSITIVE |
100 |
0.0561 |
| 48 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
78 |
0.0552 |
| 49 |
PARVOVIRUS B19 INFECTION |
49 |
0.0547 |
| 50 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
265 |
0.0520 |
| 51 |
BK VIRUS INFECTION |
175 |
0.0518 |
| 52 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
68 |
0.0516 |
| 53 |
SCEDOSPORIUM INFECTION |
36 |
0.0510 |
| 54 |
IDIOPATHIC PNEUMONIA SYNDROME |
15 |
0.0503 |
| 55 |
CYSTITIS HAEMORRHAGIC |
202 |
0.0501 |
| 56 |
UREAPLASMA INFECTION |
19 |
0.0466 |
| 57 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
13 |
0.0458 |
| 58 |
BRONCHIOLITIS OBLITERANS SYNDROME |
8 |
0.0457 |
| 59 |
BRONCHOALVEOLAR LAVAGE ABNORMAL |
9 |
0.0433 |
| 60 |
ADENOVIRAL HAEMORRHAGIC CYSTITIS |
9 |
0.0433 |
| 61 |
GLOMERULOSCLEROSIS |
27 |
0.0427 |
| 62 |
ADENOVIRAL HEPATITIS |
10 |
0.0426 |
| 63 |
CONFABULATION |
11 |
0.0415 |
| 64 |
EPSTEIN-BARR VIRUS INFECTION |
256 |
0.0409 |
| 65 |
HERPES SIMPLEX TEST POSITIVE |
8 |
0.0402 |
| 66 |
COMPLICATIONS OF TRANSPLANTED LUNG |
12 |
0.0391 |
| 67 |
BACTERIAL TRANSLOCATION |
12 |
0.0379 |
| 68 |
FUNGAL SEPSIS |
31 |
0.0373 |
| 69 |
LUNG TRANSPLANT REJECTION |
24 |
0.0364 |
| 70 |
GRAFT VERSUS HOST DISEASE IN SKIN |
80 |
0.0363 |
| 71 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
26 |
0.0362 |
| 72 |
URINARY TRACT INFLAMMATION |
13 |
0.0361 |
| 73 |
DISSEMINATED MUCORMYCOSIS |
14 |
0.0355 |
| 74 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
62 |
0.0350 |
| 75 |
ENGRAFT FAILURE |
10 |
0.0348 |
| 76 |
ADENOVIRUS INFECTION |
100 |
0.0344 |
| 77 |
FUSARIUM INFECTION |
24 |
0.0343 |
| 78 |
KERATITIS FUNGAL |
7 |
0.0337 |
| 79 |
EYE INFECTION FUNGAL |
13 |
0.0336 |
| 80 |
PNEUMOCYSTIS JIROVECII INFECTION |
40 |
0.0335 |
| 81 |
GRAFT VERSUS HOST DISEASE IN LUNG |
16 |
0.0335 |
| 82 |
COMPLICATIONS OF TRANSPLANTED LIVER |
12 |
0.0333 |
| 83 |
ENTEROCOLITIS VIRAL |
10 |
0.0329 |
| 84 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
70 |
0.0329 |
| 85 |
PATHOGEN RESISTANCE |
297 |
0.0326 |
| 86 |
ACUTE ON CHRONIC LIVER FAILURE |
7 |
0.0324 |
| 87 |
PULMONARY NECROSIS |
11 |
0.0323 |
| 88 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
89 |
0.0322 |
| 89 |
BLADDER HYPERTROPHY |
14 |
0.0317 |
| 90 |
BURKHOLDERIA CEPACIA COMPLEX INFECTION |
9 |
0.0315 |
| 91 |
OPHTHALMIC HERPES SIMPLEX |
18 |
0.0312 |
| 92 |
GLOMERULONEPHROPATHY |
8 |
0.0312 |
| 93 |
ACUTE GRAFT VERSUS HOST DISEASE |
143 |
0.0312 |
| 94 |
CONDUCTIVE DEAFNESS |
10 |
0.0312 |
| 95 |
GRAFT VERSUS HOST DISEASE |
224 |
0.0311 |
| 96 |
RETINAL ISCHAEMIA |
19 |
0.0311 |
| 97 |
INCISION SITE PAIN |
36 |
0.0306 |
| 98 |
CD4 LYMPHOCYTES INCREASED |
7 |
0.0300 |
| 99 |
RED BLOOD CELLS URINE POSITIVE |
29 |
0.0300 |
| 100 |
BLOOD BETA-D-GLUCAN INCREASED |
9 |
0.0293 |
| 101 |
MORAXELLA INFECTION |
8 |
0.0292 |
| 102 |
INFECTION REACTIVATION |
33 |
0.0288 |
| 103 |
TRANSPLANT REJECTION |
229 |
0.0286 |
| 104 |
RED BLOOD CELL SCHISTOCYTES PRESENT |
9 |
0.0278 |
| 105 |
TOXOPLASMOSIS |
30 |
0.0278 |
| 106 |
CEREBRAL ASPERGILLOSIS |
17 |
0.0276 |
| 107 |
ACINETOBACTER INFECTION |
30 |
0.0274 |
| 108 |
DRUG RESISTANCE |
678 |
0.0264 |
| 109 |
HUMAN POLYOMAVIRUS INFECTION |
14 |
0.0264 |
| 110 |
ENCEPHALITIS HERPES |
13 |
0.0263 |
| 111 |
INTUSSUSCEPTION |
25 |
0.0262 |
| 112 |
RETINAL SCAR |
12 |
0.0260 |
| 113 |
CENTRAL NERVOUS SYSTEM NECROSIS |
7 |
0.0255 |
| 114 |
CEREBRAL TOXOPLASMOSIS |
23 |
0.0246 |
| 115 |
ASPERGILLOSIS |
32 |
0.0245 |
| 116 |
TRANSPLANT DYSFUNCTION |
41 |
0.0230 |
| 117 |
ADRENAL MASS |
19 |
0.0229 |
| 118 |
STENOTROPHOMONAS INFECTION |
31 |
0.0228 |
| 119 |
HUMAN HERPESVIRUS 6 INFECTION |
43 |
0.0227 |
| 120 |
ASPERGILLUS TEST POSITIVE |
7 |
0.0227 |
| 121 |
ENTEROCOCCAL BACTERAEMIA |
24 |
0.0226 |
| 122 |
POLYOMAVIRUS VIRAEMIA |
24 |
0.0226 |
| 123 |
CONGENITAL APLASIA |
7 |
0.0225 |
| 124 |
ENTEROCOCCAL INFECTION |
108 |
0.0223 |
| 125 |
GRAFT LOSS |
16 |
0.0221 |
| 126 |
ASPERGILLUS INFECTION |
144 |
0.0219 |
| 127 |
NEPHROPATHY TOXIC |
244 |
0.0217 |
| 128 |
CHRONIC GRAFT VERSUS HOST DISEASE |
77 |
0.0213 |
| 129 |
CYSTITIS VIRAL |
8 |
0.0209 |
| 130 |
THROMBOTIC MICROANGIOPATHY |
200 |
0.0205 |
| 131 |
BRAIN COMPRESSION |
8 |
0.0200 |
| 132 |
PHARYNGEAL ABSCESS |
10 |
0.0199 |
| 133 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
149 |
0.0198 |
| 134 |
MUCORMYCOSIS |
51 |
0.0196 |
| 135 |
GRAFT VERSUS HOST DISEASE IN LIVER |
14 |
0.0196 |
| 136 |
VIRAEMIA |
27 |
0.0195 |
| 137 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
18 |
0.0194 |
| 138 |
IMMUNE RECONSTITUTION SYNDROME |
25 |
0.0194 |
| 139 |
KLEBSIELLA INFECTION |
98 |
0.0194 |
| 140 |
SEPTIC EMBOLUS |
16 |
0.0192 |
| 141 |
MACULAR FIBROSIS |
13 |
0.0192 |
| 142 |
RESPIRATORY TRACT INFECTION FUNGAL |
10 |
0.0189 |
| 143 |
ENGRAFTMENT SYNDROME |
11 |
0.0186 |
| 144 |
ECZEMA NUMMULAR |
9 |
0.0184 |
| 145 |
HERPES SIMPLEX REACTIVATION |
7 |
0.0184 |
| 146 |
LIVER TRANSPLANT REJECTION |
33 |
0.0184 |
| 147 |
TRANSPLANT FAILURE |
45 |
0.0183 |
| 148 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
13 |
0.0181 |
| 149 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
7 |
0.0180 |
| 150 |
CHRONIC ALLOGRAFT NEPHROPATHY |
14 |
0.0179 |
| 151 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
40 |
0.0176 |
| 152 |
T-LYMPHOCYTE COUNT DECREASED |
12 |
0.0176 |
| 153 |
PSEUDOMONAL BACTERAEMIA |
15 |
0.0176 |
| 154 |
KIDNEY TRANSPLANT REJECTION |
84 |
0.0175 |
| 155 |
TRACHEOBRONCHITIS |
13 |
0.0169 |
| 156 |
DELAYED GRAFT FUNCTION |
12 |
0.0169 |
| 157 |
MENINGITIS VIRAL |
23 |
0.0168 |
| 158 |
GENITAL LESION |
7 |
0.0165 |
| 159 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
165 |
0.0164 |
| 160 |
PNEUMONIA PSEUDOMONAL |
25 |
0.0163 |
| 161 |
RENAL TRANSPLANT FAILURE |
16 |
0.0162 |
| 162 |
MARROW HYPERPLASIA |
11 |
0.0161 |
| 163 |
KIDNEY FIBROSIS |
28 |
0.0161 |
| 164 |
OESOPHAGITIS ULCERATIVE |
11 |
0.0161 |
| 165 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
37 |
0.0158 |
| 166 |
GASTRIC FISTULA |
7 |
0.0157 |
| 167 |
DIFFUSE ALVEOLAR DAMAGE |
18 |
0.0157 |
| 168 |
MENINGOENCEPHALITIS HERPETIC |
7 |
0.0156 |
| 169 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
25 |
0.0156 |
| 170 |
BRONCHOPULMONARY ASPERGILLOSIS |
120 |
0.0155 |
| 171 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
51 |
0.0154 |
| 172 |
BACTERIAL SEPSIS |
50 |
0.0153 |
| 173 |
HYPHAEMA |
8 |
0.0153 |
| 174 |
METAPNEUMOVIRUS INFECTION |
12 |
0.0153 |
| 175 |
OBLITERATIVE BRONCHIOLITIS |
20 |
0.0152 |
| 176 |
DISSEMINATED ASPERGILLOSIS |
7 |
0.0148 |
| 177 |
APLASIA PURE RED CELL |
51 |
0.0148 |
| 178 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
416 |
0.0147 |
| 179 |
SYSTEMIC MYCOSIS |
17 |
0.0146 |
| 180 |
VARICELLA ZOSTER VIRUS INFECTION |
30 |
0.0145 |
| 181 |
STRONGYLOIDIASIS |
23 |
0.0142 |
| 182 |
PULMONARY MYCOSIS |
11 |
0.0141 |
| 183 |
BRAIN HERNIATION |
42 |
0.0140 |
| 184 |
ENCEPHALITIS VIRAL |
17 |
0.0140 |
| 185 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA |
8 |
0.0135 |
| 186 |
ALVEOLAR PROTEINOSIS |
8 |
0.0135 |
| 187 |
NEUROLOGICAL DECOMPENSATION |
31 |
0.0134 |
| 188 |
HYPERPLASIA |
12 |
0.0133 |
| 189 |
RETINITIS |
23 |
0.0133 |
| 190 |
BOTULISM |
11 |
0.0133 |
| 191 |
CAMPYLOBACTER INFECTION |
11 |
0.0132 |
| 192 |
STREPTOCOCCAL BACTERAEMIA |
14 |
0.0129 |
| 193 |
VIRAL LOAD INCREASED |
50 |
0.0129 |
| 194 |
FUNGAEMIA |
20 |
0.0127 |
| 195 |
INTRACRANIAL MASS |
12 |
0.0127 |
| 196 |
CORNEAL PERFORATION |
8 |
0.0127 |
| 197 |
BONE MARROW TOXICITY |
15 |
0.0127 |
| 198 |
ABDOMINAL COMPARTMENT SYNDROME |
8 |
0.0126 |
| 199 |
VENOOCCLUSIVE DISEASE |
31 |
0.0124 |
| 200 |
RENAL TUBULAR INJURY |
15 |
0.0123 |
| 201 |
VENOOCCLUSIVE LIVER DISEASE |
61 |
0.0123 |
| 202 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
61 |
0.0122 |
| 203 |
NEPHROGENIC DIABETES INSIPIDUS |
14 |
0.0121 |
| 204 |
LYMPHOCELE |
8 |
0.0120 |
| 205 |
VIRAL MUTATION IDENTIFIED |
44 |
0.0119 |
| 206 |
GRAFT COMPLICATION |
7 |
0.0119 |
| 207 |
RETINAL VASCULITIS |
14 |
0.0118 |
| 208 |
COMPUTERISED TOMOGRAM THORAX ABNORMAL |
8 |
0.0116 |
| 209 |
ACTINIC KERATOSIS |
30 |
0.0115 |
| 210 |
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA |
9 |
0.0114 |
| 211 |
PNEUMONIA KLEBSIELLA |
21 |
0.0114 |
| 212 |
RENAL TUBULAR ATROPHY |
10 |
0.0113 |
| 213 |
HERPES ZOSTER DISSEMINATED |
9 |
0.0112 |
| 214 |
PSEUDOMONAS INFECTION |
96 |
0.0112 |
| 215 |
PROTEUS INFECTION |
8 |
0.0111 |
| 216 |
HYPOPROTEINAEMIA |
21 |
0.0111 |
| 217 |
PNEUMONIA STREPTOCOCCAL |
12 |
0.0109 |
| 218 |
OSMOTIC DEMYELINATION SYNDROME |
8 |
0.0108 |
| 219 |
PNEUMONIA CRYPTOCOCCAL |
10 |
0.0106 |
| 220 |
KLEBSIELLA BACTERAEMIA |
10 |
0.0105 |
| 221 |
PNEUMOMEDIASTINUM |
19 |
0.0105 |
| 222 |
NEUTROPENIC INFECTION |
10 |
0.0104 |
| 223 |
LYMPHADENOPATHY MEDIASTINAL |
20 |
0.0104 |
| 224 |
ARTERIAL RUPTURE |
8 |
0.0104 |
| 225 |
APLASTIC ANAEMIA |
54 |
0.0103 |
| 226 |
STAPHYLOCOCCAL SEPSIS |
51 |
0.0103 |
| 227 |
MULTIPLE-DRUG RESISTANCE |
32 |
0.0103 |
| 228 |
SUBCUTANEOUS EMPHYSEMA |
10 |
0.0102 |
| 229 |
SUPERINFECTION BACTERIAL |
8 |
0.0101 |
| 230 |
LUNG ABSCESS |
21 |
0.0100 |
| 231 |
URETERIC STENOSIS |
8 |
0.0100 |
| 232 |
RENAL TUBULAR DISORDER |
28 |
0.0099 |
| 233 |
BRAIN ABSCESS |
25 |
0.0099 |
| 234 |
LYMPHOPROLIFERATIVE DISORDER |
29 |
0.0099 |
| 235 |
CEREBRAL ARTERY EMBOLISM |
12 |
0.0098 |
| 236 |
KLEBSIELLA SEPSIS |
11 |
0.0098 |
| 237 |
ESCHERICHIA SEPSIS |
28 |
0.0097 |
| 238 |
HYPOGAMMAGLOBULINAEMIA |
62 |
0.0094 |
| 239 |
HISTIOCYTOSIS HAEMATOPHAGIC |
28 |
0.0094 |
| 240 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
25 |
0.0094 |
| 241 |
PANCYTOPENIA |
525 |
0.0094 |
| 242 |
ESCHERICHIA BACTERAEMIA |
22 |
0.0093 |
| 243 |
HYPERLACTACIDAEMIA |
25 |
0.0093 |
| 244 |
PULMONARY CAVITATION |
8 |
0.0092 |
| 245 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
20 |
0.0090 |
| 246 |
IMMUNE THROMBOCYTOPENIA |
41 |
0.0089 |
| 247 |
LEUKAEMIA RECURRENT |
15 |
0.0089 |
| 248 |
NEUROPSYCHIATRIC SYMPTOMS |
8 |
0.0089 |
| 249 |
LYMPHOPENIA |
124 |
0.0088 |
| 250 |
ENTEROCOCCAL SEPSIS |
7 |
0.0086 |
| 251 |
DYSBIOSIS |
7 |
0.0085 |
| 252 |
ENCEPHALITIS |
59 |
0.0085 |
| 253 |
MICROANGIOPATHY |
8 |
0.0085 |
| 254 |
SYSTEMIC CANDIDA |
21 |
0.0084 |
| 255 |
BICYTOPENIA |
16 |
0.0082 |
| 256 |
PNEUMONIA VIRAL |
26 |
0.0081 |
| 257 |
OPPORTUNISTIC INFECTION |
15 |
0.0081 |
| 258 |
STEROID DIABETES |
12 |
0.0080 |
| 259 |
OPTIC ATROPHY |
13 |
0.0080 |
| 260 |
ILEAL ULCER |
8 |
0.0079 |
| 261 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
21 |
0.0078 |
| 262 |
RETINAL TOXICITY |
8 |
0.0078 |
| 263 |
EPIDIDYMITIS |
9 |
0.0077 |
| 264 |
LARGE INTESTINAL ULCER |
21 |
0.0077 |
| 265 |
ENTEROBACTER INFECTION |
13 |
0.0077 |
| 266 |
RETINAL DEGENERATION |
10 |
0.0077 |
| 267 |
GASTROINTESTINAL VIRAL INFECTION |
8 |
0.0077 |
| 268 |
HERPES OPHTHALMIC |
10 |
0.0076 |
| 269 |
OESOPHAGEAL CANDIDIASIS |
30 |
0.0075 |
| 270 |
PNEUMONIA BACTERIAL |
69 |
0.0075 |
| 271 |
BILE DUCT STENOSIS |
9 |
0.0075 |
| 272 |
CLOSTRIDIUM DIFFICILE COLITIS |
78 |
0.0073 |
| 273 |
CYTOPENIA |
90 |
0.0073 |
| 274 |
HAEMOLYTIC URAEMIC SYNDROME |
17 |
0.0073 |
| 275 |
URETERIC OBSTRUCTION |
10 |
0.0073 |
| 276 |
SQUAMOUS CELL CARCINOMA OF SKIN |
44 |
0.0073 |
| 277 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
10 |
0.0073 |
| 278 |
LEUKOPENIA |
363 |
0.0072 |
| 279 |
VITREOUS HAEMORRHAGE |
20 |
0.0072 |
| 280 |
ABDOMINAL INFECTION |
18 |
0.0070 |
| 281 |
PULMONARY HAEMORRHAGE |
55 |
0.0070 |
| 282 |
CD4 LYMPHOCYTES DECREASED |
15 |
0.0070 |
| 283 |
PLATELET TRANSFUSION |
9 |
0.0070 |
| 284 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
15 |
0.0070 |
| 285 |
HERPES SIMPLEX |
45 |
0.0069 |
| 286 |
RESTRICTIVE PULMONARY DISEASE |
8 |
0.0068 |
| 287 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
26 |
0.0068 |
| 288 |
CRYPTOCOCCOSIS |
11 |
0.0067 |
| 289 |
HEART TRANSPLANT REJECTION |
7 |
0.0067 |
| 290 |
APRAXIA |
10 |
0.0067 |
| 291 |
HEPATOSPLENOMEGALY |
17 |
0.0066 |
| 292 |
OLIGURIA |
41 |
0.0066 |
| 293 |
CLOSTRIDIUM COLITIS |
8 |
0.0066 |
| 294 |
PARAINFLUENZAE VIRUS INFECTION |
10 |
0.0066 |
| 295 |
GENERALISED OEDEMA |
80 |
0.0065 |
| 296 |
BONE MARROW FAILURE |
131 |
0.0064 |
| 297 |
HAEMORRHAGE INTRACRANIAL |
96 |
0.0064 |
| 298 |
ADENOCARCINOMA OF COLON |
12 |
0.0064 |
| 299 |
GASTROINTESTINAL ULCER |
14 |
0.0063 |
| 300 |
HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME |
7 |
0.0063 |
| 301 |
LIP HAEMORRHAGE |
8 |
0.0063 |
| 302 |
PSEUDOMEMBRANOUS COLITIS |
14 |
0.0063 |
| 303 |
JC VIRUS INFECTION |
10 |
0.0063 |
| 304 |
NOROVIRUS INFECTION |
9 |
0.0062 |
| 305 |
SEPTIC SHOCK |
270 |
0.0062 |
| 306 |
MULTI-ORGAN FAILURE |
106 |
0.0061 |
| 307 |
CENTRAL NERVOUS SYSTEM INFECTION |
7 |
0.0061 |
| 308 |
PNEUMONIA FUNGAL |
24 |
0.0061 |
| 309 |
GENE MUTATION |
12 |
0.0061 |
| 310 |
LYMPHOCYTOSIS |
13 |
0.0060 |
| 311 |
DISSEMINATED INTRAVASCULAR COAGULATION |
85 |
0.0060 |
| 312 |
IMMUNE-MEDIATED LUNG DISEASE |
11 |
0.0060 |
| 313 |
MYELOSUPPRESSION |
217 |
0.0060 |
| 314 |
GASTROINTESTINAL STROMAL TUMOUR |
16 |
0.0060 |
| 315 |
HYPERAMMONAEMIA |
30 |
0.0060 |
| 316 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
106 |
0.0060 |
| 317 |
DEVICE RELATED SEPSIS |
12 |
0.0060 |
| 318 |
END STAGE RENAL DISEASE |
108 |
0.0059 |
| 319 |
LEUKOENCEPHALOPATHY |
22 |
0.0059 |
| 320 |
NOSOCOMIAL INFECTION |
13 |
0.0059 |
| 321 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
56 |
0.0059 |
| 322 |
CORNEAL OPACITY |
8 |
0.0059 |
| 323 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
7 |
0.0058 |
| 324 |
RESPIRATORY DISTRESS |
160 |
0.0058 |
| 325 |
MENINGITIS CRYPTOCOCCAL |
10 |
0.0057 |
| 326 |
BACTERAEMIA |
67 |
0.0056 |
| 327 |
PROTEIN URINE PRESENT |
28 |
0.0056 |
| 328 |
BILIRUBIN CONJUGATED INCREASED |
13 |
0.0056 |
| 329 |
STAPHYLOCOCCAL BACTERAEMIA |
24 |
0.0055 |
| 330 |
HEPATITIS CHOLESTATIC |
33 |
0.0055 |
| 331 |
NOCARDIOSIS |
14 |
0.0055 |
| 332 |
RESPIRATORY FAILURE |
399 |
0.0055 |
| 333 |
OESOPHAGEAL ULCER |
21 |
0.0055 |
| 334 |
NORMOCYTIC ANAEMIA |
8 |
0.0054 |
| 335 |
RETINAL DETACHMENT |
50 |
0.0054 |
| 336 |
QUADRIPARESIS |
9 |
0.0054 |
| 337 |
EYELID PAIN |
11 |
0.0054 |
| 338 |
ENTEROCOLITIS |
31 |
0.0054 |
| 339 |
MACULAR OEDEMA |
30 |
0.0053 |
| 340 |
ENCEPHALITIS AUTOIMMUNE |
7 |
0.0053 |
| 341 |
CYSTOID MACULAR OEDEMA |
10 |
0.0053 |
| 342 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
8 |
0.0053 |
| 343 |
MECHANICAL VENTILATION |
10 |
0.0053 |
| 344 |
LIVER ABSCESS |
17 |
0.0052 |
| 345 |
GASTROINTESTINAL NECROSIS |
15 |
0.0051 |
| 346 |
HYPOALBUMINAEMIA |
40 |
0.0051 |
| 347 |
URINARY TRACT INFECTION BACTERIAL |
13 |
0.0051 |
| 348 |
PSEUDOMONAL SEPSIS |
9 |
0.0051 |
| 349 |
HAEMORRHAGE URINARY TRACT |
13 |
0.0051 |
| 350 |
CACHEXIA |
26 |
0.0050 |
| 351 |
ORGANISING PNEUMONIA |
25 |
0.0050 |
| 352 |
HISTOPLASMOSIS DISSEMINATED |
8 |
0.0050 |
| 353 |
INTRA-ABDOMINAL HAEMORRHAGE |
12 |
0.0050 |
| 354 |
CANDIDA INFECTION |
84 |
0.0050 |
| 355 |
GASTRIC ULCER |
93 |
0.0049 |
| 356 |
PNEUMOPERITONEUM |
9 |
0.0049 |
| 357 |
BRAIN DEATH |
15 |
0.0048 |
| 358 |
RETINAL HAEMORRHAGE |
34 |
0.0048 |
| 359 |
LUNG INFILTRATION |
42 |
0.0048 |
| 360 |
HAEMODYNAMIC INSTABILITY |
36 |
0.0047 |
| 361 |
RETINAL OEDEMA |
9 |
0.0047 |
| 362 |
PULMONARY TUBERCULOSIS |
20 |
0.0047 |
| 363 |
HYPERCAPNIA |
14 |
0.0046 |
| 364 |
INFECTIOUS PLEURAL EFFUSION |
7 |
0.0046 |
| 365 |
MULTI-ORGAN DISORDER |
9 |
0.0046 |
| 366 |
HAEMATOTOXICITY |
43 |
0.0045 |
| 367 |
COMA SCALE ABNORMAL |
13 |
0.0045 |
| 368 |
ORGAN FAILURE |
18 |
0.0045 |
| 369 |
MEGACOLON |
7 |
0.0045 |
| 370 |
HYDROCEPHALUS |
24 |
0.0044 |
| 371 |
ENTERITIS |
28 |
0.0044 |
| 372 |
SOFT TISSUE INFECTION |
8 |
0.0044 |
| 373 |
LYMPHOCYTE COUNT DECREASED |
76 |
0.0043 |
| 374 |
ESCHERICHIA INFECTION |
35 |
0.0043 |
| 375 |
CANDIDIASIS |
17 |
0.0042 |
| 376 |
DUODENITIS |
13 |
0.0042 |
| 377 |
NEUTROPHIL COUNT INCREASED |
43 |
0.0042 |
| 378 |
CEREBRAL HAEMATOMA |
14 |
0.0042 |
| 379 |
HYPERBILIRUBINAEMIA |
43 |
0.0041 |
| 380 |
IRIDOCYCLITIS |
13 |
0.0041 |
| 381 |
MALNUTRITION |
46 |
0.0041 |
| 382 |
CORNEAL DISORDER |
9 |
0.0041 |
| 383 |
PULMONARY ALVEOLAR HAEMORRHAGE |
23 |
0.0041 |
| 384 |
PYELONEPHRITIS ACUTE |
8 |
0.0041 |
| 385 |
PNEUMONIA STAPHYLOCOCCAL |
8 |
0.0041 |
| 386 |
NEUTROPENIA |
548 |
0.0040 |
| 387 |
SPLENOMEGALY |
47 |
0.0040 |
| 388 |
STEM CELL TRANSPLANT |
10 |
0.0040 |
| 389 |
RENAL IMPAIRMENT |
336 |
0.0040 |
| 390 |
LUNG INFECTION |
62 |
0.0040 |
| 391 |
RENAL TUBULAR NECROSIS |
39 |
0.0040 |
| 392 |
BONE MARROW DISORDER |
12 |
0.0040 |
| 393 |
HISTOPLASMOSIS |
7 |
0.0040 |
| 394 |
TOXIC ENCEPHALOPATHY |
20 |
0.0039 |
| 395 |
OTITIS MEDIA |
13 |
0.0039 |
| 396 |
SHOCK HAEMORRHAGIC |
32 |
0.0039 |
| 397 |
HYPERURICAEMIA |
16 |
0.0039 |
| 398 |
BLOOD UREA INCREASED |
65 |
0.0039 |
| 399 |
CAPILLARY LEAK SYNDROME |
8 |
0.0039 |
| 400 |
BLOOD HIV RNA INCREASED |
7 |
0.0039 |
| 401 |
CEREBRAL VENOUS THROMBOSIS |
7 |
0.0039 |
| 402 |
LUNG OPACITY |
10 |
0.0038 |
| 403 |
SEPSIS |
420 |
0.0038 |
| 404 |
DIFFUSE LARGE B-CELL LYMPHOMA |
29 |
0.0038 |
| 405 |
TOXIC EPIDERMAL NECROLYSIS |
57 |
0.0037 |
| 406 |
VASCULAR DEVICE INFECTION |
17 |
0.0037 |
| 407 |
ELECTROLYTE IMBALANCE |
43 |
0.0037 |
| 408 |
ACUTE RESPIRATORY FAILURE |
71 |
0.0037 |
| 409 |
TUBULOINTERSTITIAL NEPHRITIS |
69 |
0.0037 |
| 410 |
TACHYPNOEA |
50 |
0.0037 |
| 411 |
ULCERATIVE KERATITIS |
10 |
0.0036 |
| 412 |
NEPHROGENIC SYSTEMIC FIBROSIS |
11 |
0.0036 |
| 413 |
HYPERTRANSAMINASAEMIA |
25 |
0.0036 |
| 414 |
PARESIS |
8 |
0.0036 |
| 415 |
FIBROSIS |
11 |
0.0036 |
| 416 |
BRAIN OEDEMA |
45 |
0.0036 |
| 417 |
BRONCHIECTASIS |
24 |
0.0036 |
| 418 |
CHOLANGITIS |
22 |
0.0035 |
| 419 |
ESCHERICHIA URINARY TRACT INFECTION |
15 |
0.0035 |
| 420 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
12 |
0.0035 |
| 421 |
BACTERIAL INFECTION |
65 |
0.0035 |
| 422 |
HEPATITIS B REACTIVATION |
11 |
0.0035 |
| 423 |
HAEMODIALYSIS |
29 |
0.0034 |
| 424 |
HYPOMAGNESAEMIA |
48 |
0.0034 |
| 425 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
189 |
0.0034 |
| 426 |
MUCOSAL INFLAMMATION |
90 |
0.0034 |
| 427 |
DIARRHOEA HAEMORRHAGIC |
32 |
0.0034 |
| 428 |
IMMUNOSUPPRESSION |
30 |
0.0034 |
| 429 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
20 |
0.0034 |
| 430 |
ASCITES |
99 |
0.0034 |
| 431 |
GASTROINTESTINAL INFECTION |
30 |
0.0033 |
| 432 |
THROMBOCYTOPENIA |
370 |
0.0033 |
| 433 |
GUILLAIN-BARRE SYNDROME |
16 |
0.0033 |
| 434 |
AUTOIMMUNE HEPATITIS |
23 |
0.0033 |
| 435 |
KERATITIS |
10 |
0.0033 |
| 436 |
CLONUS |
9 |
0.0033 |
| 437 |
PNEUMOTHORAX |
52 |
0.0033 |
| 438 |
BLOOD ALBUMIN DECREASED |
26 |
0.0033 |
| 439 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
27 |
0.0033 |
| 440 |
B-CELL LYMPHOMA |
11 |
0.0032 |
| 441 |
HYPERVOLAEMIA |
16 |
0.0032 |
| 442 |
LUNG CONSOLIDATION |
9 |
0.0032 |
| 443 |
HEPATIC NECROSIS |
12 |
0.0032 |
| 444 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
9 |
0.0032 |
| 445 |
HERPES VIRUS INFECTION |
18 |
0.0031 |
| 446 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
19 |
0.0031 |
| 447 |
PNEUMONITIS |
85 |
0.0031 |
| 448 |
LARGE INTESTINAL HAEMORRHAGE |
7 |
0.0031 |
| 449 |
COLITIS |
118 |
0.0031 |
| 450 |
HYPOPHOSPHATAEMIA |
23 |
0.0031 |
| 451 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
8 |
0.0031 |
| 452 |
HEPATIC FAILURE |
93 |
0.0031 |
| 453 |
HEPATIC FUNCTION ABNORMAL |
114 |
0.0031 |
| 454 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
8 |
0.0031 |
| 455 |
LIVER TRANSPLANT |
11 |
0.0030 |
| 456 |
AGRANULOCYTOSIS |
56 |
0.0030 |
| 457 |
FUNGAL INFECTION |
98 |
0.0029 |
| 458 |
CHOLESTASIS |
56 |
0.0029 |
| 459 |
LYMPHADENITIS |
7 |
0.0029 |
| 460 |
SUSPECTED OFF LABEL USE |
13 |
0.0029 |
| 461 |
GLOMERULONEPHRITIS |
7 |
0.0029 |
| 462 |
HAEMOLYSIS |
22 |
0.0028 |
| 463 |
HYDRONEPHROSIS |
21 |
0.0028 |
| 464 |
RESPIRATORY ACIDOSIS |
11 |
0.0028 |
| 465 |
HYPERTRIGLYCERIDAEMIA |
16 |
0.0027 |
| 466 |
IMMUNE-MEDIATED ENTEROCOLITIS |
10 |
0.0027 |
| 467 |
PLEURAL EFFUSION |
165 |
0.0027 |
| 468 |
ATYPICAL PNEUMONIA |
8 |
0.0027 |
| 469 |
BLOOD CULTURE POSITIVE |
8 |
0.0027 |
| 470 |
WOUND DEHISCENCE |
9 |
0.0027 |
| 471 |
CLOSTRIDIAL INFECTION |
9 |
0.0027 |
| 472 |
HEPATOMEGALY |
26 |
0.0026 |
| 473 |
BRONCHOPNEUMONIA |
9 |
0.0026 |
| 474 |
HEPATIC FIBROSIS |
9 |
0.0026 |
| 475 |
ATAXIA |
31 |
0.0026 |
| 476 |
DERMATITIS EXFOLIATIVE |
13 |
0.0026 |
| 477 |
INTERSTITIAL LUNG DISEASE |
125 |
0.0026 |
| 478 |
SHOCK |
59 |
0.0026 |
| 479 |
INTESTINAL ISCHAEMIA |
14 |
0.0025 |
| 480 |
HEPATITIS |
65 |
0.0025 |
| 481 |
FEBRILE NEUTROPENIA |
168 |
0.0025 |
| 482 |
CEREBRAL ISCHAEMIA |
13 |
0.0025 |
| 483 |
FOREIGN BODY SENSATION IN EYES |
16 |
0.0025 |
| 484 |
ENDOPHTHALMITIS |
15 |
0.0025 |
| 485 |
GASTROINTESTINAL TOXICITY |
12 |
0.0025 |
| 486 |
ENDOTRACHEAL INTUBATION |
7 |
0.0025 |
| 487 |
STUPOR |
8 |
0.0025 |
| 488 |
ENCEPHALOPATHY |
61 |
0.0025 |
| 489 |
NEPHROTIC SYNDROME |
17 |
0.0025 |
| 490 |
DEVICE RELATED INFECTION |
38 |
0.0025 |
| 491 |
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
8 |
0.0025 |
| 492 |
NYSTAGMUS |
13 |
0.0024 |
| 493 |
ANURIA |
21 |
0.0024 |
| 494 |
UVEITIS |
33 |
0.0024 |
| 495 |
ORAL CANDIDIASIS |
32 |
0.0024 |
| 496 |
HYPERLIPIDAEMIA |
29 |
0.0024 |
| 497 |
CARDIAC DYSFUNCTION |
9 |
0.0024 |
| 498 |
HYPERNATRAEMIA |
12 |
0.0024 |
| 499 |
HIGH DENSITY LIPOPROTEIN DECREASED |
8 |
0.0024 |
| 500 |
TUMOUR LYSIS SYNDROME |
21 |
0.0024 |
| 501 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
61 |
0.0024 |
| 502 |
BLOOD CREATININE INCREASED |
151 |
0.0023 |
| 503 |
FAILURE TO THRIVE |
12 |
0.0023 |
| 504 |
LARGE INTESTINE PERFORATION |
16 |
0.0023 |
| 505 |
TONSILLITIS |
12 |
0.0023 |
| 506 |
ASPIRATION |
25 |
0.0023 |
| 507 |
GRANULOCYTOPENIA |
13 |
0.0023 |
| 508 |
NEUROLOGICAL SYMPTOM |
13 |
0.0023 |
| 509 |
DEPRESSIVE SYMPTOM |
8 |
0.0023 |
| 510 |
CEREBRAL HAEMORRHAGE |
81 |
0.0023 |
| 511 |
HYPOKALAEMIA |
104 |
0.0023 |
| 512 |
BASAL CELL CARCINOMA |
35 |
0.0022 |
| 513 |
RENAL FAILURE ACUTE |
95 |
0.0022 |
| 514 |
PRODUCT USE IN UNAPPROVED INDICATION |
552 |
0.0022 |
| 515 |
NEUROTOXICITY |
39 |
0.0022 |
| 516 |
THERAPY NON-RESPONDER |
100 |
0.0022 |
| 517 |
ABDOMINAL TENDERNESS |
11 |
0.0022 |
| 518 |
SCLERODERMA |
8 |
0.0022 |
| 519 |
MYOPATHY |
19 |
0.0022 |
| 520 |
ODYNOPHAGIA |
13 |
0.0022 |
| 521 |
HYPOXIA |
76 |
0.0022 |
| 522 |
RENAL FAILURE |
286 |
0.0022 |
| 523 |
RETINOPATHY |
8 |
0.0021 |
| 524 |
HYPERPYREXIA |
9 |
0.0021 |
| 525 |
HEMIPARESIS |
36 |
0.0021 |
| 526 |
AUTOIMMUNE THYROIDITIS |
8 |
0.0021 |
| 527 |
ACUTE KIDNEY INJURY |
323 |
0.0021 |
| 528 |
BLOOD BILIRUBIN INCREASED |
57 |
0.0021 |
| 529 |
NEUTROPENIC SEPSIS |
15 |
0.0021 |
| 530 |
MENINGITIS |
14 |
0.0021 |
| 531 |
LYMPHADENOPATHY |
74 |
0.0021 |
| 532 |
LEFT VENTRICULAR DYSFUNCTION |
14 |
0.0021 |
| 533 |
BLOOD LACTIC ACID INCREASED |
11 |
0.0021 |
| 534 |
HYPOVOLAEMIC SHOCK |
10 |
0.0021 |
| 535 |
HYPERKALAEMIA |
73 |
0.0021 |
| 536 |
ATELECTASIS |
20 |
0.0021 |
| 537 |
RALES |
12 |
0.0021 |
| 538 |
METABOLIC ACIDOSIS |
66 |
0.0021 |
| 539 |
C-REACTIVE PROTEIN INCREASED |
75 |
0.0021 |
| 540 |
LUNG DISORDER |
101 |
0.0021 |
| 541 |
DRUG LEVEL INCREASED |
34 |
0.0021 |
| 542 |
HYPOVOLAEMIA |
12 |
0.0020 |
| 543 |
VENOUS THROMBOSIS |
8 |
0.0020 |
| 544 |
COVID-19 PNEUMONIA |
24 |
0.0020 |
| 545 |
ILEUS PARALYTIC |
9 |
0.0020 |
| 546 |
CREATININE RENAL CLEARANCE DECREASED |
8 |
0.0020 |
| 547 |
FACIAL PARALYSIS |
17 |
0.0020 |
| 548 |
HEPATOTOXICITY |
44 |
0.0020 |
| 549 |
INTRACRANIAL PRESSURE INCREASED |
11 |
0.0020 |
| 550 |
OFF LABEL USE |
1720 |
0.0020 |
| 551 |
ACIDOSIS |
15 |
0.0020 |
| 552 |
INTESTINAL PERFORATION |
22 |
0.0020 |
| 553 |
EOSINOPHILIA |
34 |
0.0019 |
| 554 |
PHOTOPHOBIA |
36 |
0.0019 |
| 555 |
STAPHYLOCOCCAL INFECTION |
63 |
0.0019 |
| 556 |
PERICARDIAL EFFUSION |
44 |
0.0019 |
| 557 |
CENTRAL NERVOUS SYSTEM LESION |
26 |
0.0019 |
| 558 |
PERIPHERAL SENSORY NEUROPATHY |
11 |
0.0019 |
| 559 |
ALTERED STATE OF CONSCIOUSNESS |
40 |
0.0018 |
| 560 |
DECUBITUS ULCER |
15 |
0.0018 |
| 561 |
PULMONARY TOXICITY |
13 |
0.0018 |
| 562 |
PERITONITIS |
38 |
0.0018 |
| 563 |
CLOSTRIDIUM DIFFICILE INFECTION |
40 |
0.0018 |
| 564 |
ACUTE HEPATIC FAILURE |
25 |
0.0018 |
| 565 |
HEPATIC ENCEPHALOPATHY |
17 |
0.0018 |
| 566 |
LEUKAEMIA |
17 |
0.0018 |
| 567 |
RASH MACULO-PAPULAR |
40 |
0.0018 |
| 568 |
NECROSIS |
10 |
0.0018 |
| 569 |
CYTOKINE RELEASE SYNDROME |
36 |
0.0018 |
| 570 |
EYE PAIN |
101 |
0.0018 |
| 571 |
GASTROINTESTINAL INFLAMMATION |
14 |
0.0018 |
| 572 |
HAEMOLYTIC ANAEMIA |
16 |
0.0018 |
| 573 |
MENINGITIS ASEPTIC |
8 |
0.0018 |
| 574 |
INTENTIONAL PRODUCT USE ISSUE |
156 |
0.0018 |
| 575 |
TREATMENT FAILURE |
147 |
0.0018 |
| 576 |
WHITE BLOOD CELL COUNT INCREASED |
68 |
0.0018 |
| 577 |
ENDOCARDITIS |
9 |
0.0018 |
| 578 |
PYREXIA |
607 |
0.0018 |
| 579 |
LYMPHOMA |
27 |
0.0017 |
| 580 |
MYOCARDITIS |
20 |
0.0017 |
| 581 |
PROTEINURIA |
33 |
0.0017 |
| 582 |
PYELONEPHRITIS |
15 |
0.0017 |
| 583 |
HAEMATURIA |
59 |
0.0017 |
| 584 |
LIVER FUNCTION TEST ABNORMAL |
50 |
0.0017 |
| 585 |
GASTROENTERITIS |
25 |
0.0017 |
| 586 |
PLEURISY |
10 |
0.0017 |
| 587 |
METASTASIS |
12 |
0.0017 |
| 588 |
DRUG LEVEL DECREASED |
17 |
0.0017 |
| 589 |
PRODUCT USE ISSUE |
310 |
0.0016 |
| 590 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
26 |
0.0016 |
| 591 |
LIVER INJURY |
40 |
0.0016 |
| 592 |
UROSEPSIS |
15 |
0.0016 |
| 593 |
COAGULOPATHY |
27 |
0.0016 |
| 594 |
ABDOMINAL ABSCESS |
7 |
0.0016 |
| 595 |
RIGHT VENTRICULAR FAILURE |
11 |
0.0016 |
| 596 |
DUODENAL ULCER |
11 |
0.0016 |
| 597 |
GASTRITIS |
41 |
0.0016 |
| 598 |
ANAEMIA |
297 |
0.0016 |
| 599 |
NEUTROPHIL COUNT DECREASED |
63 |
0.0015 |
| 600 |
VASCULITIS |
18 |
0.0015 |
| 601 |
HYPONATRAEMIA |
86 |
0.0015 |
| 602 |
DERMATITIS BULLOUS |
11 |
0.0015 |
| 603 |
SERUM FERRITIN INCREASED |
8 |
0.0015 |
| 604 |
SKIN INFECTION |
17 |
0.0015 |
| 605 |
RENAL CYST |
12 |
0.0015 |
| 606 |
DRUG-INDUCED LIVER INJURY |
47 |
0.0015 |
| 607 |
TYPE 1 DIABETES MELLITUS |
9 |
0.0015 |
| 608 |
URINE OUTPUT DECREASED |
13 |
0.0015 |
| 609 |
POSTOPERATIVE WOUND INFECTION |
10 |
0.0015 |
| 610 |
GENERAL PHYSICAL CONDITION ABNORMAL |
10 |
0.0015 |
| 611 |
DISEASE PROGRESSION |
171 |
0.0014 |
| 612 |
AUTOIMMUNE DISORDER |
14 |
0.0014 |
| 613 |
PLATELET COUNT DECREASED |
152 |
0.0014 |
| 614 |
STATUS EPILEPTICUS |
16 |
0.0014 |
| 615 |
GASTROINTESTINAL HAEMORRHAGE |
118 |
0.0014 |
| 616 |
TORSADE DE POINTES |
11 |
0.0014 |
| 617 |
HYPERGLYCAEMIA |
51 |
0.0014 |
| 618 |
CARDIOGENIC SHOCK |
20 |
0.0014 |
| 619 |
CARDIAC ARREST |
115 |
0.0014 |
| 620 |
BLOOD URIC ACID INCREASED |
8 |
0.0014 |
| 621 |
HEPATITIS ACUTE |
9 |
0.0014 |
| 622 |
EYELID PTOSIS |
14 |
0.0014 |
| 623 |
POLYP |
9 |
0.0014 |
| 624 |
RESPIRATORY DISORDER |
41 |
0.0014 |
| 625 |
ALANINE AMINOTRANSFERASE INCREASED |
84 |
0.0014 |
| 626 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
14 |
0.0014 |
| 627 |
CIRCULATORY COLLAPSE |
23 |
0.0013 |
| 628 |
OCULAR DISCOMFORT |
15 |
0.0013 |
| 629 |
HEPATIC CYTOLYSIS |
17 |
0.0013 |
| 630 |
LEUKOCYTOSIS |
24 |
0.0013 |
| 631 |
HEPATITIS C |
16 |
0.0013 |
| 632 |
PNEUMONIA |
429 |
0.0013 |
| 633 |
COLITIS ULCERATIVE |
59 |
0.0013 |
| 634 |
TRANSAMINASES INCREASED |
29 |
0.0013 |
| 635 |
POST PROCEDURAL COMPLICATION |
25 |
0.0013 |
| 636 |
GRAND MAL CONVULSION |
12 |
0.0013 |
| 637 |
NEPHROPATHY |
12 |
0.0013 |
| 638 |
ACUTE MYELOID LEUKAEMIA |
20 |
0.0013 |
| 639 |
WOUND INFECTION |
14 |
0.0013 |
| 640 |
PAPULE |
9 |
0.0013 |
| 641 |
DIALYSIS |
18 |
0.0013 |
| 642 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
28 |
0.0013 |
| 643 |
DISEASE RECURRENCE |
60 |
0.0013 |
| 644 |
CHOLECYSTITIS |
15 |
0.0013 |
| 645 |
HERPES ZOSTER |
72 |
0.0013 |
| 646 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
21 |
0.0012 |
| 647 |
LIVER DISORDER |
55 |
0.0012 |
| 648 |
INFECTION |
177 |
0.0012 |
| 649 |
THERAPY PARTIAL RESPONDER |
19 |
0.0012 |
| 650 |
HYPOCALCAEMIA |
23 |
0.0012 |
| 651 |
HYPERCALCAEMIA |
15 |
0.0012 |
| 652 |
SKIN LESION |
33 |
0.0012 |
| 653 |
CARDIAC FAILURE ACUTE |
8 |
0.0012 |
| 654 |
JAUNDICE |
32 |
0.0012 |
| 655 |
PULMONARY OEDEMA |
53 |
0.0012 |
| 656 |
ASPARTATE AMINOTRANSFERASE INCREASED |
62 |
0.0012 |
| 657 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
46 |
0.0012 |
| 658 |
HEPATITIS B |
7 |
0.0012 |
| 659 |
ADRENAL INSUFFICIENCY |
14 |
0.0012 |
| 660 |
PULMONARY HYPERTENSION |
24 |
0.0012 |
| 661 |
RESPIRATORY TRACT INFECTION |
30 |
0.0012 |
| 662 |
FOETAL GROWTH RESTRICTION |
7 |
0.0012 |
| 663 |
GENERALISED TONIC-CLONIC SEIZURE |
19 |
0.0011 |
| 664 |
NO THERAPEUTIC RESPONSE |
14 |
0.0011 |
| 665 |
PULMONARY FIBROSIS |
22 |
0.0011 |
| 666 |
WHITE BLOOD CELL COUNT DECREASED |
124 |
0.0011 |
| 667 |
CONDITION AGGRAVATED |
346 |
0.0011 |
| 668 |
HAEMOGLOBIN DECREASED |
116 |
0.0011 |
| 669 |
DRUG INEFFECTIVE |
1484 |
0.0011 |
| 670 |
STEVENS-JOHNSON SYNDROME |
25 |
0.0011 |
| 671 |
EPILEPSY |
34 |
0.0011 |
| 672 |
MOUTH HAEMORRHAGE |
8 |
0.0011 |
| 673 |
MENTAL STATUS CHANGES |
30 |
0.0011 |
| 674 |
BLOOD TRIGLYCERIDES INCREASED |
19 |
0.0011 |
| 675 |
PERICARDITIS |
18 |
0.0011 |
| 676 |
HEPATOCELLULAR INJURY |
15 |
0.0011 |
| 677 |
SMALL INTESTINAL OBSTRUCTION |
13 |
0.0011 |
| 678 |
PETECHIAE |
11 |
0.0011 |
| 679 |
HEPATOCELLULAR CARCINOMA |
8 |
0.0011 |
| 680 |
FOLLICULITIS |
11 |
0.0010 |
| 681 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
26 |
0.0010 |
| 682 |
ILEUS |
13 |
0.0010 |
| 683 |
MELAENA |
23 |
0.0010 |
| 684 |
PNEUMONIA ASPIRATION |
26 |
0.0010 |
| 685 |
UPPER RESPIRATORY TRACT INFECTION |
48 |
0.0010 |
| 686 |
DRUG TOXICITY |
14 |
0.0010 |
| 687 |
EYE MOVEMENT DISORDER |
7 |
0.0010 |
| 688 |
ECCHYMOSIS |
7 |
0.0010 |
| 689 |
PURPURA |
9 |
0.0010 |
| 690 |
ANOREXIA |
13 |
0.0010 |
| 691 |
PANCREATITIS |
53 |
0.0010 |
| 692 |
MOUTH ULCERATION |
21 |
0.0010 |
| 693 |
VIRAL INFECTION |
33 |
0.0010 |
| 694 |
SINUS TACHYCARDIA |
14 |
0.0010 |
| 695 |
POLYURIA |
8 |
0.0010 |
| 696 |
CONJUNCTIVITIS |
18 |
0.0010 |
| 697 |
MYELODYSPLASTIC SYNDROME |
14 |
0.0010 |
| 698 |
VISUAL ACUITY REDUCED |
32 |
0.0010 |
| 699 |
EYE IRRITATION |
55 |
0.0010 |
| 700 |
CARDIOMYOPATHY |
14 |
0.0009 |
| 701 |
MUSCLE ATROPHY |
12 |
0.0009 |
| 702 |
PULMONARY MASS |
14 |
0.0009 |
| 703 |
INTRAOCULAR PRESSURE INCREASED |
12 |
0.0009 |
| 704 |
PANCREATITIS ACUTE |
21 |
0.0009 |
| 705 |
ORAL HERPES |
18 |
0.0009 |
| 706 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
8 |
0.0009 |
| 707 |
DIABETES MELLITUS |
70 |
0.0009 |
| 708 |
PULMONARY CONGESTION |
12 |
0.0009 |
| 709 |
HEPATIC CIRRHOSIS |
17 |
0.0009 |
| 710 |
DRUG ERUPTION |
16 |
0.0009 |
| 711 |
HAEMOPTYSIS |
25 |
0.0009 |
| 712 |
MYOSITIS |
8 |
0.0009 |
| 713 |
STOMATITIS |
53 |
0.0009 |
| 714 |
GASTROINTESTINAL DISORDER |
78 |
0.0009 |
| 715 |
NEOPLASM |
10 |
0.0009 |
| 716 |
PROCEDURAL PAIN |
24 |
0.0009 |
| 717 |
URINARY TRACT INFECTION |
147 |
0.0009 |
| 718 |
RENAL DISORDER |
40 |
0.0009 |
| 719 |
ERYTHEMA MULTIFORME |
8 |
0.0009 |
| 720 |
TACHYCARDIA |
75 |
0.0008 |
| 721 |
OCULAR HYPERAEMIA |
40 |
0.0008 |
| 722 |
EYE INFLAMMATION |
8 |
0.0008 |
| 723 |
HYPOTENSION |
168 |
0.0008 |
| 724 |
BLINDNESS |
34 |
0.0008 |
| 725 |
DRUG INTERACTION |
132 |
0.0008 |
| 726 |
LACRIMATION INCREASED |
25 |
0.0008 |
| 727 |
FLUID OVERLOAD |
12 |
0.0008 |
| 728 |
BLOOD MAGNESIUM DECREASED |
7 |
0.0008 |
| 729 |
CARDIAC FAILURE |
65 |
0.0008 |
| 730 |
OBSTRUCTIVE AIRWAYS DISORDER |
9 |
0.0008 |
| 731 |
DELIRIUM |
28 |
0.0008 |
| 732 |
COMA |
38 |
0.0008 |
| 733 |
HAEMATOCHEZIA |
44 |
0.0008 |
| 734 |
CELLULITIS |
40 |
0.0008 |
| 735 |
HEPATIC ENZYME INCREASED |
54 |
0.0008 |
| 736 |
TOXICITY TO VARIOUS AGENTS |
132 |
0.0008 |
| 737 |
EYELID OEDEMA |
9 |
0.0008 |
| 738 |
POST PROCEDURAL HAEMORRHAGE |
9 |
0.0008 |
| 739 |
ATRIAL FIBRILLATION |
75 |
0.0008 |
| 740 |
SUBDURAL HAEMATOMA |
11 |
0.0008 |
| 741 |
MYOCLONUS |
9 |
0.0008 |
| 742 |
RASH ERYTHEMATOUS |
36 |
0.0008 |
| 743 |
OXYGEN SATURATION DECREASED |
42 |
0.0007 |
| 744 |
GENERAL PHYSICAL HEALTH DETERIORATION |
86 |
0.0007 |
| 745 |
BLOOD URINE PRESENT |
14 |
0.0007 |
| 746 |
CONVULSION |
42 |
0.0007 |
| 747 |
GLOMERULAR FILTRATION RATE DECREASED |
9 |
0.0007 |
| 748 |
OESOPHAGITIS |
8 |
0.0007 |
| 749 |
SEROTONIN SYNDROME |
14 |
0.0007 |
| 750 |
PRESCRIBED OVERDOSE |
14 |
0.0007 |
| 751 |
RASH PAPULAR |
16 |
0.0007 |
| 752 |
FISTULA |
8 |
0.0007 |
| 753 |
BLOOD CALCIUM DECREASED |
8 |
0.0007 |
| 754 |
BLINDNESS UNILATERAL |
10 |
0.0007 |
| 755 |
REBOUND EFFECT |
8 |
0.0007 |
| 756 |
EJECTION FRACTION DECREASED |
11 |
0.0007 |
| 757 |
DYSURIA |
26 |
0.0007 |
| 758 |
INTERNATIONAL NORMALISED RATIO INCREASED |
20 |
0.0007 |
| 759 |
DIARRHOEA |
450 |
0.0007 |
| 760 |
THROMBOSIS |
56 |
0.0007 |
| 761 |
SKIN DISORDER |
23 |
0.0007 |
| 762 |
ABSCESS |
11 |
0.0007 |
| 763 |
IMMUNE SYSTEM DISORDER |
9 |
0.0007 |
| 764 |
GLAUCOMA |
13 |
0.0007 |
| 765 |
ABDOMINAL PAIN |
157 |
0.0007 |
| 766 |
HAEMATEMESIS |
17 |
0.0007 |
| 767 |
POLYNEUROPATHY |
8 |
0.0007 |
| 768 |
APHASIA |
20 |
0.0007 |
| 769 |
HAEMATOCRIT DECREASED |
13 |
0.0007 |
| 770 |
CEREBRAL INFARCTION |
16 |
0.0007 |
| 771 |
CARDIOMEGALY |
8 |
0.0006 |
| 772 |
NERVOUS SYSTEM DISORDER |
20 |
0.0006 |
| 773 |
OSTEONECROSIS |
21 |
0.0006 |
| 774 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
18 |
0.0006 |
| 775 |
PULMONARY ARTERIAL HYPERTENSION |
9 |
0.0006 |
| 776 |
HYPOKINESIA |
9 |
0.0006 |
| 777 |
UNRESPONSIVE TO STIMULI |
16 |
0.0006 |
| 778 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
18 |
0.0006 |
| 779 |
KIDNEY INFECTION |
12 |
0.0006 |
| 780 |
OEDEMA |
33 |
0.0006 |
| 781 |
RHABDOMYOLYSIS |
25 |
0.0006 |
| 782 |
CYSTITIS |
19 |
0.0006 |
| 783 |
FULL BLOOD COUNT DECREASED |
12 |
0.0006 |
| 784 |
OSTEOPENIA |
9 |
0.0006 |
| 785 |
BODY TEMPERATURE INCREASED |
12 |
0.0006 |
| 786 |
PALLOR |
16 |
0.0006 |
| 787 |
IMPAIRED GASTRIC EMPTYING |
8 |
0.0006 |
| 788 |
SEIZURE |
67 |
0.0006 |
| 789 |
DIPLOPIA |
15 |
0.0006 |
| 790 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
41 |
0.0006 |
| 791 |
CONFUSIONAL STATE |
92 |
0.0006 |
| 792 |
HALLUCINATION, VISUAL |
12 |
0.0006 |
| 793 |
PREMATURE DELIVERY |
9 |
0.0006 |
| 794 |
EYE SWELLING |
21 |
0.0006 |
| 795 |
BLOOD PRESSURE DECREASED |
37 |
0.0006 |
| 796 |
BLOOD POTASSIUM INCREASED |
9 |
0.0006 |
| 797 |
VISION BLURRED |
76 |
0.0006 |
| 798 |
CARDIO-RESPIRATORY ARREST |
23 |
0.0005 |
| 799 |
VISUAL IMPAIRMENT |
68 |
0.0005 |
| 800 |
HYPOPHAGIA |
14 |
0.0005 |
| 801 |
PRODUCT ADMINISTRATION ERROR |
11 |
0.0005 |
| 802 |
HIATUS HERNIA |
7 |
0.0005 |
| 803 |
IMMUNODEFICIENCY |
8 |
0.0005 |
| 804 |
OSTEOPOROSIS |
22 |
0.0005 |
| 805 |
INTESTINAL OBSTRUCTION |
20 |
0.0005 |
| 806 |
TREATMENT NONCOMPLIANCE |
29 |
0.0005 |
| 807 |
CHRONIC KIDNEY DISEASE |
40 |
0.0005 |
| 808 |
HYPERTENSION |
108 |
0.0005 |
| 809 |
DISORIENTATION |
20 |
0.0005 |
| 810 |
GASTROENTERITIS VIRAL |
9 |
0.0005 |
| 811 |
LACTIC ACIDOSIS |
16 |
0.0005 |
| 812 |
DYSKINESIA |
20 |
0.0005 |
| 813 |
PULMONARY EMBOLISM |
46 |
0.0005 |
| 814 |
MUSCLE TWITCHING |
11 |
0.0005 |
| 815 |
ARRHYTHMIA |
22 |
0.0005 |
| 816 |
HALLUCINATION |
35 |
0.0005 |
| 817 |
MENTAL DISORDER |
20 |
0.0005 |
| 818 |
DIABETIC KETOACIDOSIS |
11 |
0.0005 |
| 819 |
RED BLOOD CELL COUNT DECREASED |
13 |
0.0005 |
| 820 |
DYSPHAGIA |
43 |
0.0005 |
| 821 |
URINARY RETENTION |
15 |
0.0004 |
| 822 |
OEDEMA PERIPHERAL |
54 |
0.0004 |
| 823 |
OSTEOMYELITIS |
8 |
0.0004 |
| 824 |
SKIN EXFOLIATION |
37 |
0.0004 |
| 825 |
RENAL INJURY |
13 |
0.0004 |
| 826 |
ACCIDENTAL OVERDOSE |
16 |
0.0004 |
| 827 |
BRADYCARDIA |
23 |
0.0004 |
| 828 |
PREMATURE BABY |
13 |
0.0004 |
| 829 |
DEHYDRATION |
57 |
0.0004 |
| 830 |
DRUG INTOLERANCE |
41 |
0.0004 |
| 831 |
WEIGHT DECREASED |
118 |
0.0004 |
| 832 |
LIVER FUNCTION TEST INCREASED |
9 |
0.0004 |
| 833 |
RECTAL HAEMORRHAGE |
18 |
0.0004 |
| 834 |
PRODUCTIVE COUGH |
20 |
0.0004 |
| 835 |
BLOOD PRESSURE FLUCTUATION |
10 |
0.0004 |
| 836 |
INFLUENZA |
46 |
0.0004 |
| 837 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
7 |
0.0004 |
| 838 |
NIGHT SWEATS |
13 |
0.0004 |
| 839 |
BLOOD POTASSIUM DECREASED |
12 |
0.0004 |
| 840 |
CHROMATURIA |
9 |
0.0004 |
| 841 |
COUGH |
110 |
0.0004 |
| 842 |
DECREASED APPETITE |
91 |
0.0004 |
| 843 |
GOUT |
7 |
0.0004 |
| 844 |
COGNITIVE DISORDER |
18 |
0.0004 |
| 845 |
AMNESIA |
25 |
0.0004 |
| 846 |
AGITATION |
28 |
0.0004 |
| 847 |
NEUROPATHY PERIPHERAL |
36 |
0.0004 |
| 848 |
RASH MACULAR |
13 |
0.0004 |
| 849 |
VOMITING |
174 |
0.0004 |
| 850 |
PRODUCT PRESCRIBING ISSUE |
8 |
0.0004 |
| 851 |
IMPAIRED HEALING |
12 |
0.0004 |
| 852 |
RESPIRATORY ARREST |
10 |
0.0004 |
| 853 |
EPISTAXIS |
27 |
0.0004 |
| 854 |
COVID-19 |
63 |
0.0004 |
| 855 |
ABDOMINAL PAIN LOWER |
9 |
0.0004 |
| 856 |
DEEP VEIN THROMBOSIS |
23 |
0.0004 |
| 857 |
MUSCULAR WEAKNESS |
40 |
0.0004 |
| 858 |
BONE DENSITY DECREASED |
11 |
0.0004 |
| 859 |
ANGINA PECTORIS |
10 |
0.0003 |
| 860 |
HAEMATOMA |
9 |
0.0003 |
| 861 |
INFUSION RELATED REACTION |
23 |
0.0003 |
| 862 |
DYSARTHRIA |
13 |
0.0003 |
| 863 |
ANHEDONIA |
9 |
0.0003 |
| 864 |
ACUTE MYOCARDIAL INFARCTION |
10 |
0.0003 |
| 865 |
LABORATORY TEST ABNORMAL |
10 |
0.0003 |
| 866 |
CHOLELITHIASIS |
11 |
0.0003 |
| 867 |
DERMATITIS |
7 |
0.0003 |
| 868 |
PLASMA CELL MYELOMA |
13 |
0.0003 |
| 869 |
CHILLS |
39 |
0.0003 |
| 870 |
RASH PRURITIC |
18 |
0.0003 |
| 871 |
MOOD ALTERED |
9 |
0.0003 |
| 872 |
INFLAMMATION |
17 |
0.0003 |
| 873 |
ABDOMINAL DISTENSION |
34 |
0.0003 |
| 874 |
DRY EYE |
16 |
0.0003 |
| 875 |
LETHARGY |
18 |
0.0003 |
| 876 |
CHEST DISCOMFORT |
32 |
0.0003 |
| 877 |
MOVEMENT DISORDER |
10 |
0.0003 |
| 878 |
RASH |
135 |
0.0003 |
| 879 |
SKIN ULCER |
8 |
0.0003 |
| 880 |
HYPOGLYCAEMIA |
15 |
0.0003 |
| 881 |
JOINT STIFFNESS |
8 |
0.0003 |
| 882 |
CATARACT |
18 |
0.0003 |
| 883 |
UNDERDOSE |
22 |
0.0003 |
| 884 |
BLOOD CHOLESTEROL INCREASED |
14 |
0.0003 |
| 885 |
ANGIOEDEMA |
13 |
0.0003 |
| 886 |
DYSPNOEA EXERTIONAL |
11 |
0.0003 |
| 887 |
NEOPLASM PROGRESSION |
10 |
0.0003 |
| 888 |
ERYTHEMA |
59 |
0.0003 |
| 889 |
HAEMORRHAGE |
30 |
0.0003 |
| 890 |
NEPHROLITHIASIS |
13 |
0.0003 |
| 891 |
MALIGNANT NEOPLASM PROGRESSION |
29 |
0.0003 |
| 892 |
PAIN IN JAW |
8 |
0.0003 |
| 893 |
THERAPEUTIC RESPONSE DECREASED |
17 |
0.0003 |
| 894 |
ASTHENIA |
104 |
0.0003 |
| 895 |
NO ADVERSE EVENT |
50 |
0.0003 |
| 896 |
EYE DISORDER |
9 |
0.0003 |
| 897 |
EXPOSURE DURING PREGNANCY |
17 |
0.0003 |
| 898 |
MYALGIA |
46 |
0.0003 |
| 899 |
URINARY INCONTINENCE |
8 |
0.0003 |
| 900 |
DYSPNOEA |
152 |
0.0003 |
| 901 |
CONTRAINDICATED PRODUCT ADMINISTERED |
8 |
0.0003 |
| 902 |
RHINORRHOEA |
17 |
0.0003 |
| 903 |
FOETAL EXPOSURE DURING PREGNANCY |
21 |
0.0003 |
| 904 |
MATERNAL EXPOSURE DURING PREGNANCY |
23 |
0.0003 |
| 905 |
BRONCHITIS |
19 |
0.0003 |
| 906 |
MUSCULOSKELETAL PAIN |
13 |
0.0002 |
| 907 |
NAUSEA |
192 |
0.0002 |
| 908 |
TINNITUS |
11 |
0.0002 |
| 909 |
BLOOD GLUCOSE INCREASED |
45 |
0.0002 |
| 910 |
CHEST PAIN |
43 |
0.0002 |
| 911 |
CONSTIPATION |
50 |
0.0002 |
| 912 |
HEART RATE DECREASED |
8 |
0.0002 |
| 913 |
LOSS OF CONSCIOUSNESS |
29 |
0.0002 |
| 914 |
POLLAKIURIA |
9 |
0.0002 |
| 915 |
GAIT INABILITY |
7 |
0.0002 |
| 916 |
EYE PRURITUS |
7 |
0.0002 |
| 917 |
MEDICATION ERROR |
11 |
0.0002 |
| 918 |
FLUID RETENTION |
10 |
0.0002 |
| 919 |
SINUSITIS |
20 |
0.0002 |
| 920 |
LUNG NEOPLASM MALIGNANT |
8 |
0.0002 |
| 921 |
ELECTROCARDIOGRAM QT PROLONGED |
7 |
0.0002 |
| 922 |
MALAISE |
83 |
0.0002 |
| 923 |
DEATH |
162 |
0.0002 |
| 924 |
BONE PAIN |
11 |
0.0002 |
| 925 |
BALANCE DISORDER |
16 |
0.0002 |
| 926 |
OROPHARYNGEAL PAIN |
17 |
0.0002 |
| 927 |
TREMOR |
30 |
0.0002 |
| 928 |
ABDOMINAL DISCOMFORT |
30 |
0.0002 |
| 929 |
SOMNOLENCE |
36 |
0.0002 |
| 930 |
BLISTER |
10 |
0.0002 |
| 931 |
CARDIAC FAILURE CONGESTIVE |
14 |
0.0002 |
| 932 |
HEADACHE |
108 |
0.0002 |
| 933 |
SLEEP DISORDER |
12 |
0.0002 |
| 934 |
HYPOAESTHESIA |
25 |
0.0002 |
| 935 |
ANAPHYLACTIC REACTION |
9 |
0.0002 |
| 936 |
OVERDOSE |
35 |
0.0002 |
| 937 |
DYSGEUSIA |
12 |
0.0002 |
| 938 |
SYNCOPE |
16 |
0.0002 |
| 939 |
INFLUENZA LIKE ILLNESS |
13 |
0.0002 |
| 940 |
THERAPY INTERRUPTED |
11 |
0.0002 |
| 941 |
HYPERSENSITIVITY |
28 |
0.0002 |
| 942 |
DRY SKIN |
20 |
0.0001 |
| 943 |
IRRITABILITY |
9 |
0.0001 |
| 944 |
EMOTIONAL DISTRESS |
18 |
0.0001 |
| 945 |
INJURY |
10 |
0.0001 |
| 946 |
PAIN IN EXTREMITY |
41 |
0.0001 |
| 947 |
GASTROOESOPHAGEAL REFLUX DISEASE |
11 |
0.0001 |
| 948 |
CEREBROVASCULAR ACCIDENT |
23 |
0.0001 |
| 949 |
NASOPHARYNGITIS |
25 |
0.0001 |
| 950 |
WHEEZING |
8 |
0.0001 |
| 951 |
VERTIGO |
8 |
0.0001 |
| 952 |
HEART RATE INCREASED |
13 |
0.0001 |
| 953 |
MOBILITY DECREASED |
9 |
0.0001 |
| 954 |
MEMORY IMPAIRMENT |
17 |
0.0001 |
| 955 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
22 |
0.0001 |
| 956 |
DYSPEPSIA |
12 |
0.0001 |
| 957 |
FALL |
39 |
0.0001 |
| 958 |
PARAESTHESIA |
18 |
0.0001 |
| 959 |
MUSCULOSKELETAL STIFFNESS |
10 |
0.0001 |
| 960 |
DEPRESSION |
25 |
0.0001 |
| 961 |
BACK PAIN |
25 |
0.0001 |
| 962 |
PAIN |
66 |
0.0001 |
| 963 |
SWELLING |
10 |
0.0001 |
| 964 |
BLOOD PRESSURE INCREASED |
16 |
0.0001 |
| 965 |
FATIGUE |
81 |
0.0001 |
| 966 |
INTENTIONAL PRODUCT MISUSE |
9 |
0.0001 |
| 967 |
ABDOMINAL PAIN UPPER |
21 |
0.0001 |
| 968 |
INSOMNIA |
27 |
0.0001 |
| 969 |
GAIT DISTURBANCE |
19 |
0.0001 |
| 970 |
DIZZINESS |
49 |
0.0001 |
| 971 |
WEIGHT INCREASED |
22 |
0.0001 |
| 972 |
PERIPHERAL SWELLING |
15 |
0.0001 |
| 973 |
ILLNESS |
10 |
0.0001 |
| 974 |
MIGRAINE |
9 |
0.0001 |
| 975 |
PRURITUS |
35 |
0.0001 |
| 976 |
URTICARIA |
15 |
0.0001 |
| 977 |
MYOCARDIAL INFARCTION |
15 |
0.0001 |
| 978 |
CARDIAC DISORDER |
8 |
0.0001 |
| 979 |
ARTHRALGIA |
35 |
0.0001 |
| 980 |
CONTUSION |
8 |
0.0001 |
| 981 |
JOINT SWELLING |
10 |
0.0001 |
| 982 |
PRODUCT DOSE OMISSION ISSUE |
23 |
0.0001 |
| 983 |
HOSPITALISATION |
12 |
0.0001 |
| 984 |
HYPERHIDROSIS |
10 |
0.0001 |
| 985 |
ANXIETY |
21 |
0.0001 |
| 986 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
14 |
0.0001 |
| 987 |
PALPITATIONS |
8 |
0.0001 |
| 988 |
ALOPECIA |
13 |
0.0001 |
| 989 |
INCORRECT DOSE ADMINISTERED |
15 |
0.0001 |
| 990 |
ASTHMA |
7 |
0.0001 |
| 991 |
PRODUCT QUALITY ISSUE |
8 |
0.0001 |
| 992 |
DRUG DOSE OMISSION |
7 |
0.0000 |
| 993 |
MUSCLE SPASMS |
7 |
0.0000 |